AHCL Share Price | Anlon Healthcare Ltd Stock Analysis & Recommendation

Q: Why is Anlon Healthcare Ltd falling/rising?

As of 18-Jul, Anlon Healthcare Ltd's stock price is falling, currently at 14.74, which reflects a decrease of 0.49 or 3.22%. The stock has underperformed compared to the sector, with a performance today that is 1.81% lower than its peers. This decline follows a trend reversal, as the stock has fallen after two consecutive days of gains. In terms of broader performance, the stock has seen a significant drop over the past week, down 5.51%, and a 1-month decline of 7.76%. Although the year-to-date performance shows a smaller decrease of 2.61%, it is still in contrast to the Sensex, which has experienced a gain of 1.29% over the same period. Despite these negative trends, there are some positive factors for the company, such as a strong ability to service debt and healthy long-term growth in net sales. However, these positives have not been enough to counteract the current downward pressure on the stock price. The moving averages indicate that while the stock is higher than the 50-day, 100-day, and 200-day averages, it is lower than the 5-day and 20-day averages, suggesting a short-term weakness. Additionally, although there has been a rise in investor participation, this has not translated into a positive price movement. Overall, the combination of recent performance trends and market conditions appears to be driving the stock price down.

Q: What does Anlon Healthcare do?

Overview: Anlon Healthcare Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.History: The incorporation year is not specified, and there are no status changes reported. The latest quarter for which sales and profit are reported is March 2026.Financial Snapshot: Most recent Net Sales: 51 Cr (Quarterly Results - Mar 2026) Most recent Net Profit: 10 Cr (Quarterly Results - Mar 2026) Market-cap value: INR 795 Cr (Micro Cap)Key Metrics: P/E: 28.00 Industry P/E: 34 Dividend Yield: 0.00% Debt-Equity: 0.07 Return on Equity: 12.98% Price-to-Book: 3.79 Contact Details: Registrar Address: Not available. Phone: Not available. Email: Not available. Website: Not available.

Q: Who are the peers of the Anlon Healthcare?

Peers: Themis Medicare, Bharat Parenter., Wanbury, Kopran, Sigachi Indust., Anuh Pharma, Shree Ganesh Rem, Kilitch Drugs, Zim Laboratories, Remus Pharma.Quality Snapshot: Excellent management risk is observed at Sigachi Indust., while Average management risk is found at Themis Medicare, Bharat Parenter., Wanbury, Kopran, Anlon Healthcare, Anuh Pharma, Shree Ganesh Rem, Zim Laboratories, and Remus Pharma. Below Average management risk is noted at Kilitch Drugs. Growth is Excellent at Anlon Healthcare and Kilitch Drugs, Good at Wanbury and Remus Pharma, and Below Average at Themis Medicare, Bharat Parenter., Kopran, Sigachi Indust., Anuh Pharma, Shree Ganesh Rem, and Zim Laboratories. Capital Structure is Excellent at Sigachi Indust. and Anuh Pharma, Good at Anlon Healthcare and Kilitch Drugs, and Average at Bharat Parenter. and Zim Laboratories, while Below Average is found at Wanbury and Themis Medicare.Return Snapshot: The peer with the highest 1-year return is Bharat Parenter. at 6.09%, while the lowest is Sigachi Indust. at -62.44%. Anlon Healthcare's 1-year return is not available for comparison. Additionally, peers with negative six-month returns include Sigachi Indust. and Anuh Pharma.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

31.81 lacs (4.15%) Volume

Shareholding (Mar 2026)

FII

0.32%

Held by 5 FIIs

DII

4.60%

Held by 1 DIIs

Promoter

52.68%

Why is Anlon Healthcare Ltd falling/rising?

19-Jul-2026

As of 18-Jul, Anlon Healthcare Ltd's stock price is at 14.74, reflecting a 3.22% decrease and underperforming compared to its sector. Despite some positive factors like strong debt servicing and long-term sales growth, the stock has declined significantly over the past week and month, indicating ongoing downward pressure.

View full answer

Which are the latest news on Anlon Healthcare?

18-Jul-2026

Anlon Healthcare Ltd is Rated Hold by MarketsMOJO
Anlon Healthcare Ltd is Rated Hold

What does Anlon Healthcare do?

11-Jun-2026

Anlon Healthcare Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 51 Cr and a net profit of 10 Cr for the quarter ending March 2026. Key metrics include a P/E ratio of 28.00 and a market cap of INR 795 Cr.

View full answer

How big is Anlon Healthcare?

11-Jun-2026

As of 10th June, Anlon Healthcare Ltd has a market capitalization of 795.00 Cr, with recent net sales of 135.40 Cr and a net profit of 32.30 Cr.

View full answer

Who are the peers of the Anlon Healthcare?

11-Jun-2026

Anlon Healthcare's peers include Themis Medicare, Bharat Parenter., Wanbury, Kopran, Sigachi Industries, Anuh Pharma, Shree Ganesh Rem, Kilitch Drugs, Zim Laboratories, and Remus Pharma. Management risk varies from excellent at Sigachi Industries to below average at Kilitch Drugs, with growth and capital structure ratings also differing among peers.

View full answer

Should I buy, sell or hold Anlon Healthcare Ltd?

03-Jun-2026

When is the next results date for Anlon Healthcare Ltd?

04-Feb-2026

The next results date for Anlon Healthcare Ltd is 09 February 2026.

View full answer

Compare Anlon Healthcare with Similar Stocks

Shree Ganesh Rem Anuh Pharma Remus Pharma.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.81 times

Healthy long term growth as Net Sales has grown by an annual rate of 65.60% and Operating profit at 0%

The company has declared Positive results for the last 2 consecutive quarters

With ROE of 13, it has a Very Expensive valuation with a 3.7 Price to Book Value

Despite the size of the company, domestic mutual funds hold only 0% of the company

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 792 Cr (Micro Cap)

P/E

28.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.07

Return on Equity

12.98%

Price to Book

3.78

Revenue and Profits:

Net Sales:

51 Cr

(Quarterly Results - Mar 2026)

Net Profit:

10 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

3.66%

6 Months

7.01%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Anlon Healthcare Ltd is Rated Hold by MarketsMOJO

Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Anlon Healthcare Ltd is Rated Hold

Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 July 2026, providing investors with the most up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Anlon Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals

Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in its daily price, the stock’s technical indicators present a nuanced picture, reflecting both resilience and caution amid broader market fluctuations.

Read full news article

Announcements

Announcement For Incorporation Of Subsidiary Company

11-Jul-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Announcement Of Incorporated Of Subsidiary Company Of Anlon Healthcare Limited

09-Jul-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Disclosure Regarding Interview/Podcast Of Chairman & Managing Director With Sumit Mehrotra Former Senior Anchor @Cnbcawaaz

06-Jul-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26

BONUS

Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

65.60%

EBIT Growth (5y)

58.45%

EBIT to Interest (avg)

9.24

Debt to EBITDA (avg)

2.57

Net Debt to Equity (avg)

0.70

Sales to Capital Employed (avg)

0.86

Tax Ratio

31.64%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

4.92%

ROCE (avg)

9.07%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.66

EV to EBIT

17.82

EV to EBITDA

17.30

EV to Capital Employed

3.49

EV to Sales

4.52

PEG Ratio

Dividend Yield

ROCE (Latest)

19.57%

ROE (Latest)

12.98%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (0.32%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

24.38%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 55.76% vs -31.84% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 90.10% vs -44.74% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "55.42",
          "val2": "35.58",
          "chgp": "55.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.91",
          "val2": "12.27",
          "chgp": "13.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.18",
          "val2": "1.51",
          "chgp": "-21.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.79",
          "val2": "5.15",
          "chgp": "90.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.10%",
          "val2": "34.49%",
          "chgp": "-9.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.08",
          "val2": "71.36",
          "chgp": "69.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.25",
          "val2": "15.03",
          "chgp": "114.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.19",
          "val2": "2.80",
          "chgp": "13.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.01",
          "val2": "3.87",
          "chgp": "365.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.64%",
          "val2": "21.06%",
          "chgp": "5.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.50",
          "val2": "120.29",
          "chgp": "46.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.14",
          "val2": "32.21",
          "chgp": "43.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.35",
          "val2": "3.72",
          "chgp": "16.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "27.81",
          "val2": "20.52",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.14%",
          "val2": "26.78%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

55.42

35.58

55.76%

Operating Profit (PBDIT) excl Other Income

13.91

12.27

13.37%

Interest

1.18

1.51

-21.85%

Exceptional Items

0.00

Standalone Net Profit

9.79

5.15

90.10%

Operating Profit Margin (Excl OI)

25.10%

34.49%

-9.39%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 55.76% vs -31.84% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 90.10% vs -44.74% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

85.50

62.00

37.90%

Operating Profit (PBDIT) excl Other Income

19.98

14.45

38.27%

Interest

1.68

1.91

-12.04%

Exceptional Items

0.00

Standalone Net Profit

12.86

6.36

102.20%

Operating Profit Margin (Excl OI)

23.37%

23.31%

0.06%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

121.08

71.36

69.67%

Operating Profit (PBDIT) excl Other Income

32.25

15.03

114.57%

Interest

3.19

2.80

13.93%

Exceptional Items

0.00

Standalone Net Profit

18.01

3.87

365.37%

Operating Profit Margin (Excl OI)

26.64%

21.06%

5.58%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

176.50

120.29

46.73%

Operating Profit (PBDIT) excl Other Income

46.14

32.21

43.25%

Interest

4.35

3.72

16.94%

Exceptional Items

0.00

Standalone Net Profit

27.81

20.52

35.53%

Operating Profit Margin (Excl OI)

26.14%

26.78%

-0.64%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Anlon Healthcare Ltd

Anlon Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available